Drugs and the skin: psoriasis
Cardiovascular risk
Interventions to reduce medication errors in adult intensive care: a systematic review
Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases
Investigation of the haemodynamic effects of exenatide in healthy male subjects
Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis
Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionate
Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics
The pharmacokinetics of oxypurinol in people with gout
Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin
NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes
Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women
Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children
Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models
Use of antidepressant serotoninergic medications and cardiac valvulopathy: a nested case–control study in the health improvement network (THIN) database
QRISK or Framingham?
Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’)
Antituberculosis Chemotherapy (Progress in Respiratory Research, ed: Bolliger CT)
Translation Section